|
1
|
Collins AJ, Kasiske B, Herzog C, et al:
Excerpts from the United States renal data system 2006 annual data
report. Am J Kidney Dis. 49(Suppl 1): S1–S296. 2007. View Article : Google Scholar
|
|
2
|
Pan HZ, Zhang L, Guo M, et al: The
oxidative stress status in diabetes mellitus and diabetic
nephropathy. Acta Diabetol. 47(Suppl 1): 71–76. 2010. View Article : Google Scholar
|
|
3
|
Kiss E, Kränzlin B, Wagenblaβ K, et al:
Lipid droplet accumulation is associated with an increase in
hyperglycemia-induced renal damage: Prevention by liver X
receptors. Am J Pathol. 182:727–741. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zain M and Awan FR: Renin Angiotensin
Aldosterone System (RAAS): Its biology and drug targets for
treating diabetic nephropathy. Pak J Pharm Sci. 27:1379–1391.
2014.PubMed/NCBI
|
|
5
|
Bhaskar LV, Mahin S, Ginila RT and
Soundararajan P: Role of the ACE ID and PPARG P12A polymorphisms in
genetic susceptibility of diabetic nephropathy in a South Indian
population. Nephrourol Mon. 5:813–817. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Duran-Salgado MB and Rubio-Guerra AF:
Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zikou X, Tellis CC, Rousouli K, Dounousi
E, Siamopoulos KC and Tselepis AD: Differential membrane expression
of toll-like receptors and intracellular cytokine induction in
peripheral blood monocytes of patients with chronic kidney disease
and diabetic nephropathy. Nephron Clin Pract. 128:399–406. 2014.
View Article : Google Scholar
|
|
8
|
Ots M, Pechter U and Tamm A:
Characteristics of progressive renal disease. Clin Chim Acta.
297:29–41. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kumar P, Rao GN, Pal BB and Pal A:
Hyperglycemia-induced oxidative stress induces apoptosis by
inhibiting PI3-kinase/Akt and ERK1/2 MAPK mediated signaling
pathway causing down-regulation of 8-oxoG-DNA glycosylase levels in
glial cells. Int J Biochem Cell Biol. 53:302–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jayakumar P, Pugalendi KV and Sankaran M:
Attenuation of hyperglycemia -mediated oxidative stress by
indole-3-carbinol and its metabolite 3, 3′-diindolylmethane in
C57BL/6J mice. J Physiol Biochem. 70:525–534. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Swaminathan S and Shah SV: Novel
approaches targeted toward oxidative stress for the treatment of
chronic kidney disease. Curr Opin Nephrol Hypertens. 17:143–148.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rösen P, Nawroth PP, King G, Möller W,
Tritschler HJ and Packer L: The role of oxidative stress in the
onset and progression of diabetes and its complications: a summary
of a congress series sponsored by UNESCO-MCBN, the American
Diabetes Association and the German Diabetes Society. Diabetes
Metab Res Rev. 17:189–212. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ha H, Hwang IA, Park JH and Lee HB: Role
of reactive oxygen species in the pathogenesis of diabetic
nephropathy. Diabetes Res Clin Pract. 82(Suppl 1): S42–S45. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li H, Zhang L, Wang F, et al: Attenuation
of glomerular injury in diabetic mice with tertbutylhydroquinone
through nuclear factor erythroid 2-related factor 2-dependent
antioxidant gene activation. Am J Nephrol. 33:289–297. 2011.
View Article : Google Scholar
|
|
15
|
Knizhnik AV, Kovaleva OV, Komelkov AV, et
al: Arf6 promotes cell proliferation via the PLD-mTORC1 and p38MAPK
pathways. J Cell Biochem. 113:360–371. 2012. View Article : Google Scholar
|
|
16
|
Lee YL, Chen CW, Liu FH, Huang YW and
Huang HM: Aclacinomycin A sensitizes K562 chronic myeloid leukemia
cells to imatinib through p38MAPK-mediated erythroid
differentiation. PLoS One. 8:e619392013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sedeek M, Callera G, Montezano A, et al:
Critical role of Nox4-based NADPH oxidase in glucose-induced
oxidative stress in the kidney: implications in type 2 diabetic
nephropathy. Am J Physiol Renal Physiol. 299:F1348–F1358. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mediavilla Bravo JJ: Guidelines for the
management of diabetes mellitus type 2. Semergen. 40:11–18. 2014.In
Spanish. View Article : Google Scholar
|
|
19
|
Chakraborty A, Chowdhury S and
Bhattacharyya M: Effect of metformin on oxidative stress,
nitrosative stress and inflammatory biomarkers in type 2 diabetes
patients. Diabetes Res Clin Pract. 93:56–62. 2011. View Article : Google Scholar
|
|
20
|
Esteghamati A, Eskandari D, Mirmiranpour
H, Noshad S, Mousavizadeh M, Hedayati M and Nakhjavani M: Effects
of metformin on markers of oxidative stress and antioxidant reserve
in patients with newly diagnosed type 2 diabetes: A randomized
clinical trial. Clin Nutr. 32:179–185. 2013. View Article : Google Scholar
|
|
21
|
Abdulkadir AA and Thanoon IA: Comparative
effects of glibenclamide and metformin on C-reactive protein and
oxidant/antioxidant status in patients with type II diabetes
mellitus. Sultan Qaboos Univ Med J. 12:55–61. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marks DC, Belov L, Davey MW, Davey RA and
Kidman AD: The MTT cell viability assay for cytotoxicity testing in
multidrug-resistant human leukemic cells. Leuk Res. 16:1165–1173.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Forbes JM, Coughlan MT and Cooper ME:
Oxidative stress as a major culprit in kidney disease in diabetes.
Diabetes. 57:1446–1454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kashihara N, Haruna Y, Kondeti VK and
Kanwar YS: Oxidative stress in diabetic nephropathy. Curr Med Chem.
17:4256–4269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Singh DK, Winocour P and Farrington K:
Oxidative stress in early diabetic nephropathy: fueling the fire.
Nat Rev Endocrinol. 7:176–184. 2011. View Article : Google Scholar
|
|
29
|
Stanton RC: Oxidative stress and diabetic
kidney disease. Curr Diab Rep. 11:330–336. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Kiritoshi S, Nishikawa T, Sonoda K, et al:
Reactive oxygen species from mitochondria induce cyclooxygenase-2
gene expression in human mesangial cells: potential role in
diabetic nephropathy. Diabetes. 52:2570–2577. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kitada M, Kume S, Imaizumi N and Koya D:
Resveratrol improves oxidative stress and protects against diabetic
nephropathy through normalization of Mn-SOD dysfunction in
AMPK/SIRT1-independent pathway. Diabetes. 60:634–643. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Barnes JL and Gorin Y: Myofibroblast
differentiation during fibrosis: role of NAD(P)H oxidases. Kidney
Int. 79:944–956. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bedard K and Krause KH: The NOX family of
ROS-generating NADPH oxidases: physiology and pathophysiology.
Physiol Rev. 87:245–313. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xia L, Wang H, Goldberg HJ, Munk S, Fantus
IG and Whiteside CI: Mesangial cell NADPH oxidase upregulation in
high glucose is protein kinase C dependent and required for
collagen IV expression. Am J Physiol Renal Physiol. 290:F345–F356.
2006. View Article : Google Scholar
|
|
35
|
Zhang L, Pang S, Deng B, et al: High
glucose induces renal mesangial cell proliferation and fibronectin
expression through JNK/NF-κB/NADPH oxidase/ROS pathway, which is
inhibited by resveratrol. Int J Biochem Cell Biol. 44:629–638.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xia L, Wang H, Munk S, Kwan J, Goldberg
HJ, Fantus IG and Whiteside CI: High glucose activates PKC-zeta and
NADPH oxidase through autocrine TGF-beta1 signaling in mesangial
cells. Am J Physiol Renal Physiol. 295:F1705–F1714. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Korashy HM and El-Kadi AO: The role of
aryl hydrocarbon receptor and the reactive oxygen species in the
modulation of glutathione transferase by heavy metals in murine
hepatoma cell lines. Chem Biol Interact. 162:237–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Nam SM, Lee MY, Koh JH, et al: Effects of
NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: the
role of reducing oxidative stress in its protective property.
Diabetes Res Clin Pract. 83:176–182. 2009. View Article : Google Scholar
|
|
39
|
Alhaider AA, Korashy HM, Sayed-Ahmed MM,
Mobark M, Kfoury H and Mansour MA: Metformin attenuates
streptozotocin-induced diabetic nephropathy in rats through
modulation of oxidative stress genes expression. Chem Biol
Interact. 192:233–242. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bellin C, de Wiza DH, Wiernsperger NF and
Rösen P: Generation of reactive oxygen species by endothelial and
smooth muscle cells: influence of hyperglycemia and metformin. Horm
Metab Res. 38:732–739. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mahrouf M, Ouslimani N, Peynet J, et al:
Metformin reduces angiotensin-mediated intracellular production of
reactive oxygen species in endothelial cells through the inhibition
of protein kinase C. Biochem Pharmacol. 72:176–183. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ouslimani N, Peynet J, Bonnefont-Rousselot
D, Thérond P, Legrand A and Beaudeux JL: Metformin decreases
intracellular production of reactive oxygen species in aortic
endothelial cells. Metabolism. 54:829–834. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Nishida M, Tanabe S, Maruyama Y, et al: G
alpha 12/13- and reactive oxygen species-dependent activation of
c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinase
by angiotensin receptor stimulation in rat neonatal cardiomyocytes.
J Biol Chem. 280:18434–18441. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zarrouki B, Soares AF, Guichardant M,
Lagarde M and Géloën A: The lipid peroxidation end-product 4-HNE
induces COX-2 expression through p38MAPK activation in 3T3-L1
adipose cell. FEBS Lett. 581:2394–2400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Nowak JZ and Wiktorowska-Owczarek A:
Neovascularization in ocular tissues: mechanisms and role of
proangiogenic and antiangiogenic factors. Klin Oczna. 106:90–97.
2004.In Polish.
|
|
46
|
Song Y, Liu J, Zhang F, Zhang J, Shi T and
Zeng Z: Antioxidant effect of quercetin against acute spinal cord
injury in rats and its correlation with the p38MAPK/iNOS signaling
pathway. Life Sci. 92:1215–1221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Luo Y, Zou P, Zou J, Wang J, Zhou D and
Liu L: Autophagy regulates ROS-induced cellular senescence via p21
in a p38 MAPKα dependent manner. Exp Gerontol. 46:860–867. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Frippiat C, Dewelle J, Remacle J and
Toussaint O: Signal transduction in H2O2-induced senescence-like
phenotype in human diploid fibroblasts. Free Radic Biol Med.
33:1334–1346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Tamagno E, Robino G, Obbili A, Bardini P,
Aragno M, Parola M and Danni O: H2O2 and 4-hydroxynonenal mediate
amyloid-induced neuronal apoptosis by activating JNKs and p38MAPK.
Exp Neurol. 180:144–155. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bae CH, Kim JW, Ye SB, Song SY, Kim YW,
Park SY and Kim YD: AMPK induces MUC5B expression via p38 MAPK in
NCI-H292 airway epithelial cells. Biochem Biophys Res Commun.
409:669–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Hauton D: Does long-term metformin
treatment increase cardiac lipoprotein lipase? Metabolism.
60:32–42. 2011. View Article : Google Scholar :
|
|
52
|
Tseng SC, Huang YC, Chen HJ, et al:
Metformin-mediated down-regulation of p38 mitogen-activated protein
kinase-dependent excision repair cross-complementing 1 decreases
DNA repair capacity and sensitizes human lung cancer cells to
paclitaxel. Biochem Pharmacol. 85:583–594. 2013. View Article : Google Scholar
|
|
53
|
Kappe C, Holst JJ, Zhang Q and Sjöholm A:
Molecular mechanisms of lipoapoptosis and metformin protection in
GLP-1 secreting cells. Biochem Biophys Res Commun. 427:91–95. 2012.
View Article : Google Scholar : PubMed/NCBI
|
